ADA: Insulin efsitora noninferior to glargine for reducing HbA1c in adults with type 2 diabetes
Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated hemoglobin (HbA1c) among adults with type 2 diabetes, according to a study published online June ...
Jun 27, 2025
0
16








